Navigation Links
Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
Date:3/28/2008

- Company Plans to Request Timely Hearing before a NASDAQ Listing

Qualifications Panel -

FREMONT, Calif., March 28 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML, VRMLD) (the "Company"), a molecular diagnostics company, announced today that on March 18, 2008, the Company received communication from The NASDAQ Stock Market ("NASDAQ") that, as a result of the Company's common stock closing at $1.00 per share or more for a minimum of 10 consecutive business days, it has achieved compliance with the minimum bid price requirement for continued listing set forth in NASDAQ Marketplace Rule 4310(c)(4) ("Rule 4310(c)(4)").

The communication follows a notice of noncompliance from NASDAQ dated September 6, 2007, which was disclosed by the Company on September 7, 2007, that indicated that the Company failed to comply with the minimum bid price requirement for continued listing set forth in Rule 4310(c)(4). The notice of noncompliance gave the Company notice that the bid price of its common stock had closed under $1.00 per share for the previous 30 business days, and stated that if the Company could not demonstrate compliance with Rule 4310(c)(4) by March 4, 2008, the NASDAQ staff would determine whether or not the Company meets The NASDAQ Capital Market initial listing criteria set forth in NASDAQ Marketplace Rule 4310(c), except for the bid price requirement.

The bid price requirement was met in part as a result of the 1-for-10 reverse stock split of the Company's outstanding common stock effected by the filing of the Company's Third Amended and Restated Certificate of Incorporation on February 29, 2008, which was disclosed by the Company on March 3, 2008. The reverse stock split was effec
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. World Think Tank on Type 1 Diabetes Meets in Miami
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)... OAKLAND, Calif., May 9 /-...d Heart Corporation (the "Company") has,aggressive... additional,capital, including through equity fina...n order to continue operations. At April 30, 2008,...oximately $0.5 million and,current liabilities of ...
(Date:5/9/2008)... TAMPA, Fla., May 9 /- The Cancer Re...f the nation,s best cancer centers including,Moffi...ans to exercise,their power over cancer by steppin...is Mother,s Day through Father,s Day., The campai...n has two,key goals: to activate Americans everywh...
(Date:5/9/2008)... MONTVALE, N.J., May 9 /- ...ounced that its subsidiary, Barr Laboratories,Inc...and Drug,Administration (FDA) for its Abbreviated ...ket a generic version of Yasmin(R) (drospirenone a...ct manufactured and marketed,by Bayer Schering Pha...
(Date:5/9/2008)... PLYMOUTH MEETING, Pa., May 9 /PRNewswire-FirstCa...announced its financial results for the,quarter en...nded March 31,2008 was $4.3 million, or $(0.24) p...oss of $4.2 million, or $(0.24) per basic and dilu... Genaera,s research and development expenses for t...
Breaking Biology Technology:WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting 2WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting 3WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting 4Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research 2Barr Announces Approval of Generic Yasmin(R) 2Barr Announces Approval of Generic Yasmin(R) 3Genaera Corporation Announces First Quarter Financial Results 2Genaera Corporation Announces First Quarter Financial Results 3Genaera Corporation Announces First Quarter Financial Results 4
... flooded by complaints of poor service from Wiscon...ing to bail out. , ,Paul La Schiazza, president o...s Wisconsin customers to be assured that SBC was n...capable of competing with the top-tier telecom com...unced that SBC Ameritech of Wisconsin would simply...
...ol will benefit customers because it is a single r...s applications, said James Le Tart, Corporate Mark...to provide a better service to customers. , , ,DL...ther objects within reports, uses drag and drop fi...generation based on periodic or exception events. ...
...on is a new kind of business model, said Christoph...t the needs of the creative tech business executiv...Fusions dynamic, open work environment serves as a...anizations looking for a workplace in a desirable ...anging from freelance professionals to growing tec...
...URG, Ill. Though electricity and telephones dont e...unities and colleges are the next highly underserv...ireless unit announced on Monday. Motorola says In...mmunities in need of broadband access today. , ,Wh...cess for its residents and students, tribal commun...
Other Biology Technology:SBC is Here to Stay 2RedPrairie Employs Report Writer to Expand and Simplify SCE Report Production 2IT Fusion to Enhance Milwaukees Entrepreneurial IT Climate 2Motorola Canopy Wires Indian Reservations 2
(Date:5/8/2008)...s, locust plagues have been viewed as one of the m...ntaneous fashion, as many as 10 billion critters c...lazing destructive paths that bring starvation and...eam of scientists led by Iain Couzin of Princeton ...ity of Oxford and the University of Sydney believe...
(Date:5/8/2008)...hree OSU researchers received grants totaling more...for the Advancement of Science and Technology unde...The OARS program backs projects with the potential...according to the OCAST Web site. Funding is award...ofit organizations to accelerate the development o...
(Date:5/7/2008)...ARBOR, N.Y. How many genes are in the human geno...tic diseases" How many mobile elements, simple se...the genome" What are the largest genes and protei...use, yeast, or bacteria" , A new handbook, A ...d other commonly asked questions. Written in ques...
(Date:5/7/2008)...ergraduate student at Rensselaer Polytechnic Insti...ugar really does help the medicine go down. In fac...he medicine. , Among the most important and comp...t just metabolism but also how cells communicate w...has put his basic knowledge of sugars to exception...
Breaking Biology News(10 mins):What's bugging locusts? 2OCAST funds OSU projects with commercial viability 2Undergrad has sweet success with invention of artificial Golgi 2Undergrad has sweet success with invention of artificial Golgi 3Insmed Appoints Dennis M Lanfear to Board Of Directors 2096 1Insmed Appoints Dennis M Lanfear to Board Of Directors 2096 2Insmed Appoints Dennis M Lanfear to Board Of Directors 2096 3Watson and Novartis Settle Lawsuit Over Exelon 28R 29 Patent Litigation 7788 1Watson and Novartis Settle Lawsuit Over Exelon 28R 29 Patent Litigation 7788 2Neurocrine Announces Closing of 24109 Million Sale and Leaseback Agreement for its Real Estate Assets 7783 1Neurocrine Announces Closing of 24109 Million Sale and Leaseback Agreement for its Real Estate Assets 7783 2Reminder 3A Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society Of Hematology 48th An 7778 1Reminder 3A Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society Of Hematology 48th An 7778 2
...esearchers in India and from The Earth Institute a...the few remaining populations of Asian elephants i...s. The results of the study, which appear in the c...ould have far-reaching implications in conservatio...her species on the Subcontinent. , Prithiviraj Fer...
...icroarray technology could be used to tailor thera... cancer patients from having to undergo painful un...journal Breast Cancer Research, researchers analys...64 genes that can be used to predict a patient,s r...or breast cancer. Identifying patients whose breas...
...n experimental treatment that spares disability fr...he current three-hour treatment standard ?a potent... , Researchers at the University of South Florida ...stered to rats two days following a stroke greatly...g the size of the stroke and resulting in greatly ...
...cientists at the Universities of Heidelberg and Ul...oratory (EMBL) in Monterotondo, Italy, have discov... determine whether they live or die after a stroke...ature Medicine, strongly suggests that new therapi...ntrolling a molecule involved in passing the signa...
Other Biology News:Genetic analysis of Asian elephants in India reveals some surprises 2Microarray technology for tailoring breast cancer therapy 2Cord blood cells may widen treatment window for stroke 2Limiting the damage in stroke 2Limiting the damage in stroke 3
Normal canine serum collected from healthy normal canines.
SHEEP ANTI HUMAN ESTRONE
Request Info
The CultureWell cell culture systems provide an integrated set-up for preparing cultured cells for staining and imaging. Each system uses medical-grade silicone gaskets preassembled with standard opt
Biology Products: